Clayton C.

Clayton C. is an accomplished professional with extensive experience in development program management and clinical research. Currently serving as Associate Director at Xenon Pharmaceuticals Inc., Clayton C. has a proven track record in managing client programs from early development through clinical phases, ensuring alignment with corporate goals. Previous roles at Evonik and New β Innovation Ltd. involved overseeing pre-clinical and clinical project development, managing stakeholder relationships, and delivering successful outcomes. Clayton C. also has a strong background as a Research Scientist at The University of Chicago, leading multidisciplinary teams in glioblastoma research, and has contributed to academia as an Adjunct Professor at North Central College and the National University of Health Sciences. Educational credentials include a PhD in Biochemistry and Molecular Biology from the University of Ottawa, an MSc in Plant Molecular Biology, and a BSc in Genetics from Western University.